TGFB1 and head and neck squamous cell carcinoma: Moreover, in order to make better clinical decisions regarding appropriate treatments for HNSCC, identification of tumour areas with activated TGF-β signalling pathway would help pathologist to assess clinical risks for metastasis, recurrence, and chemoresistance in HNSCC.